bromocriptine , a drug acting directly upon dopaminergic receptors , has been found to have a significant therapeutic action in a double-blind study of 20 patients with idiopathic parkinsonism who were already receiving conventional therapy , including levodopa .
C0006230
bromocriptine
C0030567
idiopathic parkinsonism